Dashboard
Manage Tickers

EHABEnhabit, Inc.

NYSE ehab.com


$ 8.89 $ 0.09 (0.97 %)    

Tuesday, 02-Jul-2024 14:12:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 485.87 $ 5.98 (1.25 %)
DIA $ 392.45 $ 1.61 (0.41 %)
SPY $ 547.57 $ 3.83 (0.7 %)
TLT $ 90.32 $ -0.35 (-0.38 %)
GLD $ 215.08 $ -0.19 (-0.09 %)
$ 8.75
$ 8.80
$ 8.89 x 100
$ 0.00 x 0
$ 8.77 - $ 8.98
$ 7.12 - $ 14.59
609,735
na
441M
$ 0.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-15-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 04-14-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

enhabit-releases-investor-presentation-demonstrating-execution-of-growth-strategy-and-path-to-unlock-shareholder-value-says-arexs-proposal-to-take-control-of-the-board-is-not-in-the-best-interests-of-stockholders
Enhabit Releases Investor Presentation Dem...
07/01/2024 20:20:51

Recent Results Demonstrate Improving Performance Despite HeadwindsBoard Has Taken Decisive Actions in Light of the Challenges F...

b-of-a-securities-maintains-underperform-on-enhabit-lowers-price-target-to-8
B of A Securities Maintains Underperform o...
06/27/2024 17:27:28

B of A Securities analyst Joanna Gajuk maintains Enhabit (NYSE:EHAB) with a Underperform and lowers the price target from $9...

enhabit-urges-stockholders-to-vote-for-current-board-opposes-arex-capitals-bid-for-control
Enhabit Urges Stockholders to Vote for Cur...
06/10/2024 11:49:53

Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today annou...

enhabit-provides-additional-details-on-recently-concluded-strategic-review-process-arex-capital-intends-to-nominate-seven-candidates-for-election-to-company-board
Enhabit Provides Additional Details On Rec...
05/23/2024 20:38:59

The Company is filing a preliminary proxy statement because AREX Capital Management, LP has notified the Company that it intend...

analyst-expectations-for-enhabits-future
Analyst Expectations For Enhabit's Future
05/14/2024 18:00:24

leerink-partners-upgrades-enhabit-to-market-perform-announces-85-price-target
Leerink Partners Upgrades Enhabit to Marke...
05/14/2024 17:48:30

Leerink Partners analyst Whit Mayo upgrades Enhabit (NYSE:EHAB) from Underperform to Market Perform and announces $8.5 price...

jefferies-downgrades-enhabit-to-hold-lowers-price-target-to-875
Jefferies Downgrades Enhabit to Hold, Lowe...
05/09/2024 17:23:58

Jefferies analyst Brian Tanquilut downgrades Enhabit (NYSE:EHAB) from Buy to Hold and lowers the price target from $14 to $8...

arex-capital-expresses-disappointment-in-enhabits-strategic-review-conclusion-believes-enhabits-shares-do-not-reflect-its-intrinsic-value-or-strategic-potential
AREX Capital Expresses Disappointment In E...
05/09/2024 13:40:15

Believes Enhabit's Shares Do Not Reflect its Intrinsic Value or Strategic Potential Has Nominated Seven Highly Qualified In...

enhabit-reaffirms-fy24-eps-guidance-of-012-043-vs-025-est-revenue-1076b-1102b-vs-108b-est
Enhabit Reaffirms FY24 EPS Guidance Of $0....
05/08/2024 20:44:13

GUIDANCEThe Company reaffirmed its full-year 2024 guidance as follows:  ($ in millions, except per share data)2024 Guidance Net...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
05/08/2024 20:31:13

enhabit-says-after-evaluating-a-full-range-of-strategic-alternatives-including-a-potential-sale-merger-or-other-transaction-the-board-unanimously-determined-that-continuing-to-execute-on-the-companys-strategic-plan-commences-planned-board-transition
Enhabit Says After Evaluating A Full Range...
05/08/2024 20:19:19

Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced Enhabit's Board of Directors (the &#...

enhabit-q1-adj-007-beats-004-estimate-sales-26240m-miss-26793m-estimate
Enhabit Q1 Adj $0.07 Beats $0.04 Estimate,...
05/08/2024 20:15:50

Enhabit (NYSE:EHAB) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.04 by 75 per...

breaking-down-enhabit-3-analysts-share-their-views
Breaking Down Enhabit: 3 Analysts Share Th...
03/11/2024 16:01:08

td-cowen-maintains-market-perform-on-enhabit-lowers-price-target-to-11
TD Cowen Maintains Market Perform on Enhab...
03/11/2024 14:13:46

TD Cowen analyst Ryan Langston maintains Enhabit (NYSE:EHAB) with a Market Perform and lowers the price target from $12 to $11.

why-highpeak-energy-shares-are-trading-lower-by-15-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why HighPeak Energy Shares Are Trading Low...
03/07/2024 18:35:19

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-exp...

american-eagle-reports-upbeat-earnings-joins-kroger-burlington-stores-and-other-big-stocks-moving-higher-on-thursday
American Eagle Reports Upbeat Earnings, Jo...
03/07/2024 15:23:15

U.S. stocks were higher, with the Dow Jones index gaining more than 150 points on Thursday.

oppenheimer-maintains-perform-on-enhabitto-perform
Oppenheimer Maintains Perform on Enhabitto...
03/07/2024 13:01:32

Oppenheimer analyst Michael Wiederhorn maintains Enhabit (NYSE:EHAB) from Perform to Perform.

ubs-upgrades-enhabit-to-neutral-announces-95-price-target
UBS Upgrades Enhabit to Neutral, Announces...
03/07/2024 09:55:10

UBS analyst A.J. Rice upgrades Enhabit (NYSE:EHAB) from Sell to Neutral and announces $9.5 price target.

enhabit-expects-full-year-2024-net-service-revenue-of-1076b-1102b-est-1073b-adjusted-eps-of-012-043-est-022
Enhabit Expects Full-Year 2024 Net Service...
03/06/2024 22:47:01

recap-enhabit-q4-earnings
Recap: Enhabit Q4 Earnings
03/06/2024 21:20:12

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)